• JACC - October 8, 2024 Issue Summary
    Sep 30 2024

    In this episode, Dr. Valentin Fuster highlights groundbreaking research from the October 8, 2024 issue of JACC. Key studies delve into the evolving diagnostic criteria for myocarditis, the prognostic value of subclinical atherosclerosis, the arrhythmic risks in non-ischemic cardiomyopathy, and the implications of PFO closure on ischemic stroke risk, underscoring the importance of advanced imaging techniques and clinical criteria in modern cardiovascular care.

    Show more Show less
    30 mins
  • Prognostic Implications of Clinical- and Imaging Diagnostic Criteria for Myocarditis
    Sep 30 2024

    In the October 8, 2024 issue of JACC, a pivotal study explores the prognostic implications of various diagnostic criteria for myocarditis, comparing the European Society of Cardiology and the late-luis criteria. The findings reveal that while most patients can be diagnosed using ESC criteria, the combination of both sets enhances risk stratification, emphasizing the need for collaboration between clinical cardiologists and imaging specialists in managing suspected myocarditis cases.

    Show more Show less
    13 mins
  • Influence of subclinical atherosclerosis burden and progression on mortality
    Sep 30 2024

    In this episode, Dr. Valentin Fuster discusses groundbreaking research on the impact of subclinical atherosclerosis on mortality, revealing insights from a 15-year study. He emphasizes the limitations of traditional cardiovascular risk prediction tools, like the Framingham Risk Score, and calls for deeper exploration of individual risk factors for better long-term outcomes.

    Show more Show less
    12 mins
  • Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients with Non-ischemic Cardiomyopathy
    Sep 30 2024

    In this episode, Dr. Valentin Fuster discusses a groundbreaking study that evaluates the role of myocardial fibrosis in predicting sudden cardiac death and ventricular arrhythmias in patients with non-ischemic cardiomyopathy. The findings suggest that assessing fibrosis through advanced imaging techniques offers a more accurate risk stratification than the traditional reliance on left ventricular ejection fraction, ultimately refining treatment approaches for at-risk patients.

    Show more Show less
    12 mins
  • Risk of Ischemic Stroke After Patent Foramen Ovale Closure
    Sep 30 2024

    In the October 8, 2024, issue of JACC, Dr. Casper Bonison and colleagues present a study on the risks of ischemic stroke recurrence after PFO closure, revealing that while the four-year risk remains higher than the general population, it mirrors clinical trial findings. They emphasize the importance of careful patient selection and the need for further research into closure techniques and associated stroke risk factors.

    Show more Show less
    9 mins
  • Contemporary Training in American Critical Care Cardiology: Minnesota Critical Care Cardiology Education Summit
    Sep 30 2024

    In this episode, Dr. Valentin Fuster introduces a crucial consensus document on Critical Care Cardiology training, highlighting insights from leading experts at the University of Minnesota and Harvard. With the field rapidly expanding and 20% of incoming cardiology fellows expressing interest in this specialty, the panel outlines key recommendations for enhancing training programs to meet evolving demands.

    Show more Show less
    4 mins
  • ACC/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2024 Appropriate Use Criteria for Multimodality Imaging in Cardiovascular Evaluation of Patients Undergoing Nonemergent, Noncardiac Surgery
    Sep 30 2024

    In this episode, experts discuss a crucial 2024 document outlining appropriate use criteria for multimodality imaging in cardiovascular evaluation before non-emergent non-cardiac surgery, addressing the rising annual surgeries and associated cardiac risks. They delve into balancing the necessity of imaging with cost-effectiveness while exploring the potential of artificial intelligence to enhance future evaluations.

    Show more Show less
    9 mins
  • Time to Significant Benefit of Finerenone in Patients with Heart Failure | HFSA 2024
    Sep 28 2024

    Michelle M Kittleson, MD, FACC, JACC Associate Editor, speaks with author Muthiah Vaduganathan, MD on his accepted paper concerning the FINEARTS trial published in JACC.

    Show more Show less
    7 mins